• Latest Posts

Allogenic immune cell therapies to be developed as three groups join forces

RoslinCT and Lykan Bioscience combine to create cell therapy CDMO

Enrollment completed for trial looking at treatment of diabetic kidney disease

Clinical hold on trial for colorectal cancer drug lifted by FDA

T-cell therapy company AlloVir set to raise $126.6M

Oxford Biomedica sets up new project and signs LSA


Beyond Biotech podcast 6: Mogrify, +ND Capital, Poolbeg Pharma

Consortium awarded €4M towards platform for personalized cell therapies

First patient receives new immunotherapy drug for HIV in clinical trial

Evotec completes acquisition of Rigenerand

Scancell to produce and clinically validate T cell redirecting bispecific antibodies

Galapagos to acquire CellPoint and AboundBio to advance cell therapies